Literature DB >> 6308001

Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type.

P C Schmid, P V Reddy, V Natarajan, H H Schmid.   

Abstract

Rat heart contains a membrane-bound phosphodiesterase of the phospholipase D type which catalyzes the hydrolysis of 1,2-diacyl-sn-glycero-3-phospho(N-acyl)ethanolamine to N-acylethanolamine and phosphatidic acid. The enzyme also hydrolyzes the corresponding alkenylacylglycerophospho(N-acyl)ethanolamine and N-acylethanolamine lysophospholipids but not phosphatidylcholine or phosphatidylethanolamine. The activity is highest in the microsomal fraction, does not require Ca2+ or Mg2+, and is stimulated by Triton X-100. Bile salts, other ionic detergents, and Zn2+ are inhibitory. Hydrolysis occurs over a wide pH range, with the activity at acid pH being stimulated by freezing and thawing. Other rat tissues also release N-acylethanolamine from N-acylethanolamine phospholipids.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308001

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system.

Authors:  Kay Ahn; Michele K McKinney; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2008-04-23       Impact factor: 60.622

2.  Enzymological analysis of the tumor suppressor A-C1 reveals a novel group of phospholipid-metabolizing enzymes.

Authors:  Naoki Shinohara; Toru Uyama; Xing-Hua Jin; Kazuhito Tsuboi; Takeharu Tonai; Hitoshi Houchi; Natsuo Ueda
Journal:  J Lipid Res       Date:  2011-08-31       Impact factor: 5.922

Review 3.  Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.

Authors:  Stephen D Skaper; Laura Facci; Mariella Fusco; Maria Federica Della Valle; Morena Zusso; Barbara Costa; Pietro Giusti
Journal:  Inflammopharmacology       Date:  2013-11-01       Impact factor: 4.473

Review 4.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

5.  Production and physiological actions of anandamide in the vasculature of the rat kidney.

Authors:  D G Deutsch; M S Goligorsky; P C Schmid; R J Krebsbach; H H Schmid; S K Das; S K Dey; G Arreaza; C Thorup; G Stefano; L C Moore
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

6.  ABHD4 regulates multiple classes of N-acyl phospholipids in the mammalian central nervous system.

Authors:  Hyeon-Cheol Lee; Gabriel M Simon; Benjamin F Cravatt
Journal:  Biochemistry       Date:  2015-04-08       Impact factor: 3.162

7.  Differential scanning calorimetry of chain-melting phase transitions of N-acylphosphatidylethanolamines.

Authors:  M J Swamy; D Marsh; M Ramakrishnan
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

Review 8.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 9.  An overview on the biochemistry of the cannabinoid system.

Authors:  María Gómez-Ruiz; Mariluz Hernández; Rosario de Miguel; Jose A Ramos
Journal:  Mol Neurobiol       Date:  2007-06-30       Impact factor: 5.590

10.  The tumor suppressor gene H-Rev107 functions as a novel Ca2+-independent cytosolic phospholipase A1/2 of the thiol hydrolase type.

Authors:  Toru Uyama; Jun Morishita; Xing-Hua Jin; Yasuo Okamoto; Kazuhito Tsuboi; Natsuo Ueda
Journal:  J Lipid Res       Date:  2008-12-01       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.